Pay in 4 interest-free payments of $14.00 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Many tumors become addicted to autophagy for survival
It can inhibit the enzymatic activity of IDH1 R132H in vitro with an IC50 < 0
InChiKey: YUNQZQREIHWDQT-UHFFFAOYSA-N
GDC-0941 inhibits tumor cell proliferation
Targeting the JMJD2 histone demethylases to epigenetically control herpesvirus infection and reactivation from latency
PF-04979064 - PI3K/mTOR Dual Inhibitor. CAS# 1220699-06-8 hylase Many tumors become addicted toPF 04979064, CAS No. 1220699 06 8, is a highly potent and orally bioavailable PI3K mTOR dual inhibitor developed through structure based drug design. It inhibited mTOR, PI3K, , and isoforms and AKT phosphorylation with IC50 as 2. 64 nM, 0. 395 nM, 0. 111 nM, 0. 122 nM and 28. 3 nM, respectively. PF 04979064 exhibited cellular potency with an IC50 of 9. 1 nM in a BT20 cell assay. PF 04979064 exhibited excellent in vitro potency, very good solubility,